Clinical experiences of the levonorgestrel-releasing intrauterine system in Korean women with adenomyosis.
- Author:
Da Hee KIM
1
;
Dong Soo PARK
;
Mi La KIM
;
Bo Sung YOON
;
Taejong SONG
;
Mi Kyung KIM
;
Hye Sun JUN
;
Seok Ju SEONG
Author Information
1. Department of Obstetrics and Gynecology, CHA Kangnam Medical Center, CHA University, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Adenomyosis;
Dysmenorrhea;
Levonorgestrel-releasing intrauterine system;
Menorrhagia
- MeSH:
Adenomyosis;
Dysmenorrhea;
Female;
Follow-Up Studies;
Humans;
Hysterectomy;
Menorrhagia;
Metrorrhagia
- From:Korean Journal of Gynecologic Endoscopy and Minimally Invasive Surgery
2012;24(2):108-114
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: To analyze the clinical experiences of patients who treated with levonorgestrel-releasing intrauterine system (LNG-IUS) for adenomyosis associated with dysmenorrhea and/or menorrhagia. METHODS: The LNG-IUS was inserted into 103 patients who were diagnosed with adenomyosis on ultrasound examination and suffered from dysmenorrhea or menorrhagia at CHA Gangnam Medical Center between January 2009 and December 2009. Symptomatic changes of dysmenorrhea and menorrhagia, side effects, and failure rates were evaluated, retrospectively. RESULTS: During the follow-up periods, dysmenorrhea was improved in 91.4% and menorrhagia was improved in 90.4% of patients. Most common side effects were prolonged vaginal spotting in 41 (39.8%), and expulsion of LNG-IUS in 32 (31.1%) patients. Six (5.7%) patients were premature removal of LNG-IUS and 9 (8.5%) patients were underwent hysterectomy. Overall 77 (74.8%) patients continued to use of LNG-IUS. CONCLUSION: The LNG-IUS is effective treatment option for management of dysmenorrhea and menorrhagia for patients with clinical diagnosis of adenomyosis. It seemed to be an alternative treatment method before hysterectomy.
